Citigroup Inc Blueprint Medicines Corp Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Citigroup Inc holds 154,048 shares of BPMC stock, worth $19.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

154,048

Previous 304,838 49.47%

Holding current value

$19.9 Million

Previous $27 Million 26.82%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$79.22 - $128.4 $11.9 Million - $19.4 Million	-150,790 Reduced 49.47%	154,048 $19.7 Million
Q1 2025 May 12, 2025	BUY	$86.69 - $115.63 $18.2 Million - $24.2 Million	209,656 Added 220.27%	304,838 $27 Million
Q4 2024 Feb 12, 2025	SELL	$82.48 - $101.39 $3.98 Million - $4.89 Million	-48,259 Reduced 33.64%	95,182 $8.3 Million
Q3 2024 Nov 12, 2024	BUY	$84.1 - $120.5 $1.95 Million - $2.79 Million	23,189 Added 19.28%	143,441 $13.3 Million
Q2 2024 Aug 12, 2024	BUY	$85.18 - $108.78 $1.4 Million - $1.78 Million	16,389 Added 15.78%	120,252 $13 Million
Q1 2024 May 10, 2024	SELL	$73.17 - $99.79 $5.47 Million - $7.46 Million	-74,794 Reduced 41.86%	103,863 $9.85 Million
Q4 2023 Feb 09, 2024	BUY	$43.96 - $92.84 $4.71 Million - $9.95 Million	107,205 Added 150.04%	178,657 $16.5 Million
Q3 2023 Nov 09, 2023	BUY	$46.9 - $66.0 $515,196 - $725,010	10,985 Added 18.17%	71,452 $3.59 Million
Q2 2023 Aug 10, 2023	SELL	$42.2 - $66.37 $3.71 Million - $5.83 Million	-87,840 Reduced 59.23%	60,467 $3.82 Million
Q1 2023 May 11, 2023	BUY	$37.97 - $50.0 $2.32 Million - $3.05 Million	60,988 Added 69.85%	148,307 $6.67 Million
Q4 2022 Feb 09, 2023	SELL	$41.06 - $66.48 $544,332 - $881,325	-13,257 Reduced 13.18%	87,319 $3.83 Million
Q3 2022 Nov 10, 2022	BUY	$49.93 - $77.7 $632,712 - $984,614	12,672 Added 14.42%	100,576 $6.63 Million
Q2 2022 Aug 10, 2022	BUY	$45.23 - $70.15 $2.94 Million - $4.55 Million	64,922 Added 282.49%	87,904 $4.44 Million
Q1 2022 May 12, 2022	SELL	$54.1 - $110.08 $2.17 Million - $4.42 Million	-40,179 Reduced 63.61%	22,982 $1.47 Million
Q4 2021 Feb 10, 2022	BUY	$94.25 - $115.99 $382,278 - $470,455	4,056 Added 6.86%	63,161 $6.77 Million
Q3 2021 Nov 10, 2021	BUY	$80.98 - $109.47 $4.79 Million - $6.47 Million	59,105 New	59,105 $6.08 Million

Others Institutions Holding BPMC

# of Institutions

390

Shares Held

66.9M

Call Options Held

973K

Put Options Held

1.54M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account